These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7670105)

  • 1. Factor V turnover in a primate model.
    Rand MD; Hanson SR; Mann KG
    Blood; 1995 Oct; 86(7):2616-23. PubMed ID: 7670105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbohydrate moieties on the procofactor factor V, but not the derived cofactor factor Va, regulate its inactivation by activated protein C.
    Silveira JR; Kalafatis M; Tracy PB
    Biochemistry; 2002 Feb; 41(5):1672-80. PubMed ID: 11814362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimerin 1 binds factor V and activated factor V with high affinity and inhibits thrombin generation.
    Jeimy SB; Fuller N; Tasneem S; Segers K; Stafford AR; Weitz JI; Camire RM; Nicolaes GA; Hayward CP
    Thromb Haemost; 2008 Dec; 100(6):1058-67. PubMed ID: 19132231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unique in vivo modifications of coagulation factor V produce a physically and functionally distinct platelet-derived cofactor: characterization of purified platelet-derived factor V/Va.
    Gould WR; Silveira JR; Tracy PB
    J Biol Chem; 2004 Jan; 279(4):2383-93. PubMed ID: 14594814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteolysis of plasma-derived factor V following its endocytosis by megakaryocytes forms the platelet-derived factor V/Va pool.
    Ayombil F; Abdalla S; Tracy PB; Bouchard BA
    J Thromb Haemost; 2013 Aug; 11(8):1532-9. PubMed ID: 23710903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of individual activated protein C cleavage site regions in coagulation factor V for factor Va inactivation and for factor Xa activation.
    Heeb MJ; Rehemtulla A; Moussalli M; Kojima Y; Kaufman RJ
    Eur J Biochem; 1999 Feb; 260(1):64-75. PubMed ID: 10091585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional properties of recombinant factor V mutated in a potential calcium-binding site.
    Sørensen KW; Nicolaes GA; Villoutreix BO; Yamazaki T; Tans G; Rosing J; Dahlbäck B
    Biochemistry; 2004 May; 43(19):5803-10. PubMed ID: 15134454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secretable human platelet-derived factor V originates from the plasma pool.
    Camire RM; Pollak ES; Kaushansky K; Tracy PB
    Blood; 1998 Nov; 92(9):3035-41. PubMed ID: 9787136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor V C2 domain contains a major thrombin-binding site responsible for thrombin-catalyzed factor V activation.
    Suzuki H; Shima M; Nogami K; Sakurai Y; Nishiya K; Saenko EL; Tanaka I; Yoshioka A
    J Thromb Haemost; 2006 Jun; 4(6):1354-60. PubMed ID: 16706982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms of activated protein C resistance. Properties of factor V isolated from an individual with homozygosity for the Arg506 to Gln mutation in the factor V gene.
    Aparicio C; Dahlbäck B
    Biochem J; 1996 Jan; 313 ( Pt 2)(Pt 2):467-72. PubMed ID: 8573079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombin-stimulated human platelets express molecular forms of alpha-granule factor V (FV), which differ from FVa.
    Wyshock EG; Stewart GJ; Colman RW
    Thromb Haemost; 1994 Dec; 72(6):947-56. PubMed ID: 7740469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of human factor V by factor Xa and thrombin.
    Monkovic DD; Tracy PB
    Biochemistry; 1990 Feb; 29(5):1118-28. PubMed ID: 2322551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteolysis of factor Va by factor Xa and activated protein C.
    Odegaard B; Mann K
    J Biol Chem; 1987 Aug; 262(23):11233-8. PubMed ID: 3611108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of activated protein C/protein S-mediated inactivation of human factor VIII and factor V.
    Lu D; Kalafatis M; Mann KG; Long GL
    Blood; 1996 Jun; 87(11):4708-17. PubMed ID: 8639840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mechanism of inactivation of human factor V and human factor Va by activated protein C.
    Kalafatis M; Rand MD; Mann KG
    J Biol Chem; 1994 Dec; 269(50):31869-80. PubMed ID: 7989361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of monocyte-associated factor V.
    Kappelmayer J; Kunapuli SP; Wyshock EG; Colman RW
    Thromb Haemost; 1993 Aug; 70(2):273-80. PubMed ID: 7694389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential contributions of Glu96, Asp102 and Asp111 to coagulation factor V/Va metal ion binding and subunit stability.
    Song J; Talbot K; Hewitt J; MacGillivray RT; Pryzdial EL
    Biochem J; 2009 Aug; 422(2):257-64. PubMed ID: 19522703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor V.
    Kalafatis M; Krishnaswamy S; Rand MD; Mann KG
    Methods Enzymol; 1993; 222():224-36. PubMed ID: 8412796
    [No Abstract]   [Full Text] [Related]  

  • 19. Structural investigation of the A domains of human blood coagulation factor V by molecular modeling.
    Villoutreix BO; Dahlbäck B
    Protein Sci; 1998 Jun; 7(6):1317-25. PubMed ID: 9655335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteolysis of factor V by cathepsin G and elastase indicates that cleavage at Arg1545 optimizes cofactor function by facilitating factor Xa binding.
    Camire RM; Kalafatis M; Tracy PB
    Biochemistry; 1998 Aug; 37(34):11896-906. PubMed ID: 9718313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.